ES2170051T3 - Procedimiento para la produccion de proteinas utilizando proteinas fusionadas de tipo cks. - Google Patents

Procedimiento para la produccion de proteinas utilizando proteinas fusionadas de tipo cks.

Info

Publication number
ES2170051T3
ES2170051T3 ES91114296T ES91114296T ES2170051T3 ES 2170051 T3 ES2170051 T3 ES 2170051T3 ES 91114296 T ES91114296 T ES 91114296T ES 91114296 T ES91114296 T ES 91114296T ES 2170051 T3 ES2170051 T3 ES 2170051T3
Authority
ES
Spain
Prior art keywords
proteins
cks
protein
vector
hcv protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91114296T
Other languages
English (en)
Inventor
Timothy Bolling
Wlodzimierz Mandecki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2170051T3 publication Critical patent/ES2170051T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

ESTA INVENCION SE REFIERE A UN METODO CKS DE UNA SINTESIS DE PROTEINA HCV EN UN MICROBIO, QUE ESTA CARACTERIZADA POR LOS PASOS DE: (A) PROPORCIONAR UN VECTOR DE ADN CON UNA REGION DE CONTROL, UNA REGION QUE CODIFICA AL MENOS UNA PARTE DE PROTEINA CKS, Y UNA REGION QUE CODIFICA DICHA PROTEINA HCV, DICHA REGION DE CONTROL SE DIRIGE A LA EXPRESION DE DICHAS REGIONES DE CODIFICACION: (B) TRANSFORMAR DICHO MICROBIO CON EL VECTOR DE ADN; Y (C) EXPRESAR UNA PROTEINA DE FUSION DE AL MENOS UNA PARTE DE CKS Y DICHA PROTEINA HCV.ESTA INVENCION SE REFIERE TAMBIEN AL VECTOR DE CLONACION PARA CELULAS DE TRANSFORMACION PARA EXPRESAR PROTEINA HCV HETEROLOGA; A LA PROTEINA HCV ASI OBTENIDA Y A LA SECUENCIA GENETICA QUE SE VA A INSERTAR EN DICHO VECTOR DE CLONACION.
ES91114296T 1990-08-24 1991-08-26 Procedimiento para la produccion de proteinas utilizando proteinas fusionadas de tipo cks. Expired - Lifetime ES2170051T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57310390A 1990-08-24 1990-08-24

Publications (1)

Publication Number Publication Date
ES2170051T3 true ES2170051T3 (es) 2002-08-01

Family

ID=24290678

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91114296T Expired - Lifetime ES2170051T3 (es) 1990-08-24 1991-08-26 Procedimiento para la produccion de proteinas utilizando proteinas fusionadas de tipo cks.

Country Status (7)

Country Link
EP (1) EP0475182B1 (es)
KR (1) KR920004577A (es)
AT (1) ATE210186T1 (es)
AU (1) AU650038B2 (es)
DE (1) DE69132845T2 (es)
DK (1) DK0475182T3 (es)
ES (1) ES2170051T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322769A (en) * 1988-03-11 1994-06-21 Abbott Laboratories Methods for using CKS fusion proteins
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
DE69232871T2 (de) * 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
KR200180724Y1 (ko) * 1999-11-26 2000-05-15 김찬근 날개부착형 방음 방화문

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290516A4 (en) * 1986-10-24 1989-11-14 Jeffrey A Whitsett PROTEINS RELATED TO SURFACE-EFFECTIVE HYDROPHOBIC LUNG ACTIVE SUBSTANCES.
EP0318216B2 (en) * 1987-11-18 2001-08-29 Chiron Corporation NANBV diagnostics
US5124255A (en) * 1988-03-11 1992-06-23 Abbott Laboratories CKS method of protein synthesis
US5120662A (en) * 1989-05-09 1992-06-09 Abbott Laboratories Multilayer solid phase immunoassay support and method of use
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens

Also Published As

Publication number Publication date
EP0475182B1 (en) 2001-12-05
ATE210186T1 (de) 2001-12-15
DE69132845D1 (de) 2002-01-17
DE69132845T2 (de) 2002-08-01
EP0475182A2 (en) 1992-03-18
EP0475182A3 (en) 1992-10-21
AU8277791A (en) 1992-03-12
AU650038B2 (en) 1994-06-09
DK0475182T3 (da) 2002-04-02
KR920004577A (ko) 1992-03-27

Similar Documents

Publication Publication Date Title
DE69532968T2 (de) Verfahren zur sekretion thrombopoitin polypeptide
ATE318905T1 (de) Homologe des tie-rezeptortyrosinekinase liganden
DK0602144T3 (da) DNA-Sekvenser, der koder for polypeptidet gelonin
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
YU79491A (sh) Varijantni cd44-površinski proteini, dna-sekvence koje ih kodiraju i antitela protiv ovih proteina
DK1616878T3 (da) Udskilte og membranspændende polypeptider samt nukleinsyrer kodende for disse
DK1246917T3 (da) Humane Stra6-polypeptider
DE60122562D1 (de) Nukleinsäuren, die für stichodactylidae chromoproteine kodieren
NO930428L (no) Proteinstrukturen til plantetoksingelonin
ES2170051T3 (es) Procedimiento para la produccion de proteinas utilizando proteinas fusionadas de tipo cks.
ATE295890T1 (de) Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
DE69427990D1 (de) Tyrosinaseaktivator-tyrosinase-fusions-enzym
ES2111537T3 (es) Inhibidor de la ribonucleasa de placenta humana recombinante y metodo de produccion.
ATE353969T1 (de) Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide
AR017518A1 (es) Un polipeptido il-1rd9 aislado o recombinante, una proteina de fusion, una composicion, un kit, metodo para producir un anticuerpo, una composicionde la materia, un polipeptido sustancialmente puro o aislado, un compuesto de enlace, un acido nucleico aislado o recombinante que codifica a una protein
EP1434483A4 (en) NUCLEIC ACID CODING, LINKED CHROMO / FLUORESCENT DOMAINS AND METHOD OF USE THEREOF
DK0487229T3 (da) DNA, der koder for et protein, som binder til enhanceren for alfa-føtoproteingenet
WO1999055862A3 (en) Human proteins having transmembrane domains and dnas encoding these proteins
PT1217006E (pt) Polipeptidos e acidos nucleicos que os codificam
KR960034215A (ko) 헬리코박터 필로리의 항원결정부위 융합단백질인 Ub-A545의 유전공학적 제조방법
DK1241183T3 (da) Humant HCAR-agtig protein og nucleinsyrer kodende derfor
PT1251173E (pt) Polipeptidos transmembranares e excretados e acidos nucleicos que os codificam

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 475182

Country of ref document: ES